We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+11.76%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$25.4B
AUM Growth
+$2.43B
Cap. Flow
-$4.83B
Cap. Flow %
-19.02%
Top 10 Hldgs %
26.55%
Holding
1,007
New
105
Increased
201
Reduced
147
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 21.56%
2 Financials 7.89%
3 Consumer Discretionary 7.03%
4 Communication Services 6.61%
5 Healthcare 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRDN
551
Guardian Pharmacy Services
GRDN
$2.63B
$596K ﹤0.01%
27,949
-11,970
-30% -$270K
IMSRW
552
Terrestrial Energy Warrant
IMSRW
$23.6M
$588K ﹤0.01%
250,000
IFN
553
Aberdeen India Fund
IFN
$490M
$581K ﹤0.01%
35,155
-3,056
-8% -$48.6K
META icon
554
CALL
Meta Platforms (Facebook)
META
$1.51T
$576K ﹤0.01%
1,000
+500
+100% +$309K
ALCY
555
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$574K ﹤0.01%
50,000
EMO
556
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.03B
$565K ﹤0.01%
11,776
-1,024
-8% -$46.9K
AVGO icon
557
CALL
Broadcom
AVGO
$1.82T
$553K ﹤0.01%
3,300
+800
+32% +$174K
LFMD icon
558
LifeMD
LFMD
$187M
$543K ﹤0.01%
+39,857
New +$376K
FROG icon
559
JFrog
FROG
$9.84B
$535K ﹤0.01%
+12,196
New +$463K
TMUS icon
560
CALL
T-Mobile US
TMUS
$190B
$533K ﹤0.01%
2,000
+1,000
+100% +$244K
IRMD icon
561
iRadimed
IRMD
$1.22B
$530K ﹤0.01%
8,867
+4,389
+98% +$241K
XGN icon
562
Exagen
XGN
$106M
$526K ﹤0.01%
+75,413
New +$458K
HTD
563
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$918M
$525K ﹤0.01%
22,448
-1,952
-8% -$44.2K
ASG
564
Liberty All-Star Growth Fund
ASG
$325M
$524K ﹤0.01%
95,775
+8,350
+10% +$42.2K
LENZ
565
LENZ Therapeutics
LENZ
$179M
$515K ﹤0.01%
+17,565
New +$478K
PDT
566
John Hancock Premium Dividend Fund
PDT
$637M
$499K ﹤0.01%
37,856
-3,292
-8% -$41.9K
WTGUU
567
Wintergreen Acquisition Corp Unit
WTGUU
$496K ﹤0.01%
+49,244
New +$495K
SMMT icon
568
Summit Therapeutics
SMMT
$10.5B
$492K ﹤0.01%
23,117
-860
-4% -$19.6K
EXG icon
569
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.92B
$491K ﹤0.01%
56,104
-4,878
-8% -$40.4K
AISPW
570
Airship AI Holdings Warrants
AISPW
$15.6M
$490K ﹤0.01%
250,000
AOD
571
abrdn Total Dynamic Dividend Fund
AOD
$1.1B
$477K ﹤0.01%
53,866
-4,684
-8% -$39.1K
MCN
572
Madison Covered Call & Equity Strategy Fund
MCN
$118M
$473K ﹤0.01%
75,714
+17,954
+31% +$105K
LIN icon
573
CALL
Linde
LIN
$234B
$466K ﹤0.01%
+1,000
New +$456K
IONQ icon
574
IonQ
IONQ
$13.4B
$457K ﹤0.01%
+10,645
New +$357K
AORT icon
575
Artivion
AORT
$1.27B
$457K ﹤0.01%
14,690
-39,310
-73% -$1.06M

Similar funds

Calamos Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Calamos Advisors held 1,007 positions worth $25.4B, up 11% from $23B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Calamos Advisors withdrew a net $4.83B in Q2 2025, closing 91 positions and reducing 147 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $38.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Calamos Advisors opened a new position in Shift4 Payments Inc 6.00% Series A Preferred Stock worth $65M.

  • Calamos Advisors's largest Q2 2025 buy was Shift4 Payments Inc 6.00% Series A Preferred Stock: 564,562 shares worth $65M.
  • Calamos Advisors added most to Kellanova in Q2 2025, an estimated $36.9M increase.
  • Calamos Advisors's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $290M.
  • Calamos Advisors fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $38.4M.
  • Calamos Advisors's ten largest holdings make up 27% of its $25.4B portfolio in Q2 2025.
  • Calamos Advisors opened 105 new positions and closed 91 in Q2 2025.
  • Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $25.4B.

Based on Calamos Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.